TruLab, Inc. (“TruLab”) is pleased to welcome Peter Brown as the new Chief Product Officer of TruLab. Brown was previously Vice President OakNorth and brings 10+ years of product experience to TruLab starting on October 11, 2021.

“Peter Brown will make a great addition to TruLab as our Chief Product Officer,” stated Scott Ogle, Chief Executive Officer of TruLab. “Peter and I worked together at Sageworks where he impressed me with his Product Management abilities and ability to develop a product that drives revenue growth. He possesses a capability of discussing a current product with customers and then knowing exactly how to convert the findings of those conversations to modify an existing product to be even better. I am thrilled he is joining the team here at TruLab.”

While at OakNorth, Brown helped to design and build a product that transformed the commercial lending process in order to enable middle class businesses to not only survive but thrive. His career has centered around helping technology companies develop and continually improve products that revolutionize a variety of industries.

Brown received a Bachelor of Science in Computer Science from the United States Military Academy at West Point and graduated in the top 15% of his class. Brown also attended US Army Airborne School and US Army Ranger School. After graduation, Brown served his country as a Captain in the US Army from 2000-2008.

As Chief Product Officer, Brown will be head of all things related to product development and improvement. He will oversee modifications to TruLab’s headline sample tracking solution, as well as the creation of new products to meet new needs of customers.

About TruLab

TruLab, Inc. is a clinical trial technology company that provides cutting edge solutions for biological sample tracking on blockchain. TruLab’s mission is to help biotechs and pharma track samples in real-time, minimize protocol deviations and eliminate paper using innovative mobile technology.  Founded in 2018, TruLab is revolutionizing biosample tracking to advance the research and development of new medical therapies.  For more information, visit